President Biden signs law while legislators watch at the White House

President Biden signed the Inflation Reduction Act into law on Aug. 16.

Key Takeaways from New Medicare Law and 340B Implications

In Federal, LegislativeAugust 30, 2022446 Views

The landmark prescription drug pricing legislation that President Joe Biden signed this month is a mixed bag for 340B stakeholders, 340B Health Publisher and CEO Ted Slafsky says in his latest column for Omnicell.

Biden signed the Inflation Reduction Act on Aug. 16. Among other features, it lets Medicare negotiate the prices of certain costly prescription drugs and requires drug makers to pay Medicare rebates when their prices outpace inflation.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Key Takeaways from New Medicare Law and 340B Implications

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Key Takeaways from New Medicare Law and 340B Implications

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Site Footer